Rare diseases
Investigational molecules
Locations
Study of ASP1570 Alone or with Pembrolizumab for Adults with Advanced Solid Tumors
FranceStudy on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors
DenmarkStudy on the Effects of Pembrolizumab, Atezolizumab, and Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on the Effectiveness of Pembrolizumab and Lenvatinib for Patients with Resectable Mucosal Melanoma
FranceStudy of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
AustriaStudy of Pembrolizumab and Olaparib for Patients with Advanced Colorectal Cancer with DNA Repair Deficiency
SpainStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
AustriaStudy on Trastuzumab Deruxtecan for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
AustriaStudy on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors
FranceStudy of Futibatinib and Pembrolizumab for Patients with Advanced or Metastatic Bladder, Urethra, or Pelvis Cancer Not Suitable for Platinum Treatment
FranceStudy of BAT3306 or pembrolizumab with chemotherapy (carboplatin and pemetrexed) in patients with stage IV non-squamous non-small cell lung cancer
SlovakiaTell us about your condition – we search every trial in Europe and connect you with the right site.
